Emmeline Lagunes Cordoba and Derek Tracy explore a case control study that looks at cognitive change in people with schizophrenia and other psychoses in the decade following the first episode.
[read the full story...]
Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]
Carmine Pariante considers the implications of a recent case-control study, which looks at the prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis.
[read the full story...]
Samuele Cortese considers the findings of a recent nationwide self controlled case series study of the cardiovascular safety of methylphenidate use in children and young people with ADHD.
[read the full story...]
Clarissa Giebel looks at a US study on the impact of ‘house calls’ on health and social service use by people with dementia, and asks some critical questions of the research.
[read the full story...]
Marcus Munafò looks at the mounting evidence about smoking and risk of schizophrenia, including a new case-control study that provides clear evidence of a prospective association between cigarette smoking and a subsequent diagnosis of schizophrenia.
[read the full story...]
Trans-diagnostic treatment refers to an approach whereby the same underlying treatment principles are applied across diagnoses.
Here, Michelle Gregory looks at a pilot trial of trans-diagnostic cognitive behavioural therapy for a small group of people with mild learning disabilities who were in-patients in receipt of treatment for emotional difficulties.
[read the full story...]
Eleanor Kennedy writes her debut blog on a recent case-control study of people in South London, which explores the links between first-episode psychosis and the use of high potency cannabis (skunk).
[read the full story...]
To date there has been little research on vitamin D deficiency in people with learning disabilities. In this debut blog by Brant Cebulla, we look at a new case control study which sets out to answer some key questions and consider areas for further research.
[read the full story...]
Laurence Palfreyman highlights a recent BMJ study, which finds an association between Alzheimer’s disease and benzodiazepine use.
[read the full story...]
